Atlas Trials

Serum Institute of India Pvt. Ltd.

24 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Serum Institute of India Pvt. Ltd.

RecordFirmDate
Safety and Immunogenicity of a Recombinant Poliomyelitis Vaccine (rPV) in Comparison With IPOL Vaccine in Healthy Adults (NCT07688369)Serum Institute of India Pvt. Ltd.2026-07-01
Evaluation of the Antibody Persistence Beyond Five Years After Immunization With MenFiveTM (NmCV-5), a Pentavalent Meningococcal ACYWX Conjugate Vaccine (NCT07379151)Serum Institute of India Pvt. Ltd.2026-05-05
Clinical Study to Evaluate SIIPL qHPV Vaccine (CERVAVAC®) in Women Living With HIV Aged 15-25 Years (NCT06281119)Serum Institute of India Pvt. Ltd.2025-10-03
Pfs230D1 + R21 in Matrix-M1 in African School Children and Adults (NCT07147400)Serum Institute of India Pvt. Ltd.2025-08-22
An Observational Study to Assess Effectiveness and Safety of The R21/Matrix-M Malaria Vaccine (NCT07009847)Serum Institute of India Pvt. Ltd.2025-06-16
Dose-Escalating Study of Pfs230D1 in Combination With R21 in Matrix-M in African Adults (NCT06507605)Serum Institute of India Pvt. Ltd.2024-08-30
Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPV (NCT06413121)Serum Institute of India Pvt. Ltd.2024-05-09
A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL (NCT05421611)Serum Institute of India Pvt. Ltd.2023-05-11
A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL® In Healthy Infants (NCT05447377)Serum Institute of India Pvt. Ltd.2022-09-16
Evaluation of Safety and Immunogenicity of Inactivated Adjuvanted Polio Vaccine in Comparison With Licensed Inactivated Poliovirus Vaccine (NCT05163561)Serum Institute of India Pvt. Ltd.2022-01-09
Evaluation of Efficacy and Safety of VPM1002 in Comparison to BCG in Prevention of Tb Infection in Infants (NCT04351685)Serum Institute of India Pvt. Ltd.2020-11-09
Study to Evaluate the Lot to Lot Consistency of SIIPL Meningococcal ACYWX Conjugate Vaccine and to Compare Its Safety and Immunogenicity With That of Licensed Meningococcal ACWY Vaccine Menactra® in Healthy Individuals 18-85 Years of Age (NCT04358731)Serum Institute of India Pvt. Ltd.2019-12-27
A Phase 1 Safety Study of Dengusiil in Healthy Adults (NCT04035278)Serum Institute of India Pvt. Ltd.2019-12-17
Study to Assess Immunegnicity & Safety of Pentavalent Meningococcal Vaccine (NmCV-5) (NCT03964012)Serum Institute of India Pvt. Ltd.2019-08-20
Safety Study of Dengushield in Healthy Adults (NCT03883620)Serum Institute of India Pvt. Ltd.2019-03-22
Study to Check the Efficacy and Safety of Recombinant BCG Vaccine in Prevention of TB Recurrence (NCT03152903)Serum Institute of India Pvt. Ltd.2017-12-15
Clinical Study of Meningococcal ACYWX Conjugate Vaccine, in 12-16 Month Olds (NCT03295318)Serum Institute of India Pvt. Ltd.2017-11-15
Study on Liquid Bovine Rotavirus Pentavalent Vaccine (LBRV-PV) to Evaluate Lot-to-Lot Consistency and to Compare Non-Inferiority With ROTASIIL (Lyophilized BRV-PV) in Healthy Infants in India (NCT03474055)Serum Institute of India Pvt. Ltd.2017-10-30
Phase III Study on Rotavirus Vaccine to Evaluate Lot-to-lot Consistency and Interference With Routine UIP Immunization (NCT02584816)Serum Institute of India Pvt. Ltd.2015-11-01
Study to Evaluate the Safety and Immunogenicity of VPM1002 in Comparison With BCG in HIV-exposed/-Unexposed Newborn Infants in South Africa (NCT02391415)Serum Institute of India Pvt. Ltd.2015-06-01
Study Comparing DTP-HB-Hib by Disposable-Syringe Jet Injector To Vaccination By Needle And Syringe In Infants (NCT02409095)Serum Institute of India Pvt. Ltd.2015-01-01
Safety & Immunogenicity of MMR Vaccine by DSJI to That by Needle-Syringe in 15-18 Months Old Children (NCT02253407)Serum Institute of India Pvt. Ltd.2014-09-01
A Clinical Trial to Study the Effect and Safety of Rotavirus Vaccine Against Severe Rotavirus Gastroenteritis in Healthy Indian Infants (NCT02133690)Serum Institute of India Pvt. Ltd.2014-05-01
A Clinical Trial to Assess the Safety of a Measles Vaccine (Dry Powder) Administered by Two Different Devices (NCT01557699)Serum Institute of India Pvt. Ltd.2012-03-01

Track Serum Institute of India Pvt. Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.